Text Size
3040 studies found for:    "Depressive Disorder"

Modify this search | How to Use Search Results

Show Display Options
Rank Status Study
1 Completed Safety and Efficacy Study in Patients With Major Depressive Disorder
Conditions: Depressive Disorder;   Major Depressive Disorder (MDD);   Major Depressive Episode
Interventions: Drug: GSK163090 Tablets;   Drug: GSK163090 Placebo Tablets
2 Active, not recruiting Safety and Tolerability of Oral OPC-34712 as Adjunctive Therapy in Adults With Major Depressive Disorder (the Orion Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Intervention: Drug: OPC-34712 + ADT
3 Recruiting A Study of Flexible-dose Brexpiprazole as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder, the Delphinus Trial
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: Brexpiprazole;   Drug: Seroquel XR;   Drug: Placebo
4 Withdrawn Brain Imaging, Genetics and Treatment for Major Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Other: Citalopram
5 Active, not recruiting Study of the Safety and Efficacy of Fixed Dose OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Pyxis Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
6 Recruiting Study of the Safety and Efficacy of Two Fixed Doses of OPC-34712 as Adjunctive Therapy in the Treatment of Adults With Major Depressive Disorder (the Polaris Trial)
Conditions: Depressive Disorder;   Depression;   Depressive Disorder, Major;   Mood Disorders;   Mental Disorders
Interventions: Drug: OPC-34712 + ADT;   Drug: Placebo + ADT
7 Terminated Prevention of Depression in HIV/HCV Co-infected Substance Abuse Patients
Conditions: Hepatitis C;   Depressive Disorder, Major;   Depressive Disorder;   Depression;   HIV Infections
Interventions: Behavioral: Hepatitis C educational support groups;   Behavioral: Cognitive Behavioral Therapy skills based group sessions
8 Completed A Study of the Effectiveness and Safety of Risperidone to Augment SSRI Therapy in Patients With Treatment-resistant Depression
Conditions: Depressive Disorder;   Depressive Disorder, Major;   Depression
Intervention: Drug: risperidone
9 Completed N-methylglycine (Sarcosine) Treatment for Depression
Conditions: Major Depressive Disorder;   Depression;   Major Depression
Interventions: Drug: citalopram;   Drug: sarcosine
10 Completed Study Evaluating DVS-233 SR in Adult Outpatients With Major Depressive Disorder
Conditions: Depression;   Depressive Disorder;   Major Depressive Disorder
Intervention: Drug: DVS-233 SR
11 Completed Clinical Trials of Two Non-Drug Treatments for Chronic Depression
Conditions: Mood Disorders;   Depressive Disorders;   Depression;   Chronic Depression;   Nonseasonal Depression
Interventions: Device: Bright light box;   Device: Negative ion generator
12 Completed Evaluating Brain Responses to Facial Expressions in Major Depressive Disorder
Conditions: Current Major Depressive Disorder;   Healthy;   Remitted Major Depressive Disorder
Intervention:
13 Completed Associations Between Depression and Cardiovascular Disease - a Study of Patients With Late Onset Depression
Conditions: Depression;   Major Depressive Disorder;   Cardiovascular Disease;   Coronary Artery Disease
Intervention:
14 Withdrawn Imaging Serotonin 5HT1A Receptors in Patients With Major Depressive Disorder
Conditions: Major Depression;   Unipolar Depression;   Depression;   Anxiety Disorder
Intervention: Other: Antidepressant (SSRI)
15 Completed A Study of SR58611A in the Prevention of Depression Relapse in Patients With Major Depressive Disorder
Conditions: Depressive Disorder;   Major Depression
Intervention: Drug: SR58611A
16 Completed
Has Results 		Study Evaluating Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR) In The Treatment Of Child and Adolescent Outpatients With Major Depressive Disorder
Condition: Depressive Disorder, Major Depressive Disorder
Intervention: Drug: Desvenlafaxine Succinate Sustained-Release Tablets (DVS SR)
17 Completed Study Of GW679769 In Major Depressive Disorder
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
18 Recruiting Evaluation of a Stepped Care Approach to Manage Depression in Diabetes
Conditions: Major Depression;   Minor Depression;   Sub-Threshold Depression;   Diabetes Mellitus;   Inflammation
Interventions: Behavioral: Step 1: Diabetes-Specific CBT (5 group sessions);   Behavioral: Step 2: Depression-Specific CBT (6 single sessions);   Behavioral: Step 3: Referral to Psychotherapist and/or Psychiatrist;   Behavioral: Standard Diabetes Education
19 Terminated Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features
Conditions: Major Depressive Disorder;   Major Depressive Disorder w/ Psychotic Features;   Metabolic Syndrome
Intervention:
20 Completed Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)
Conditions: Depressive Disorder, Major;   Major Depressive Disorder (MDD)
Intervention: Drug: GW679769
To Top

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
† Indicates status has not been verified in more than two years